Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 113,909,183
- Total 13F value
- $333,909,974
- Share change
- +8,042,909
- Put/Call ratio
- 190%
- SEC-reported price per share
- $2.93
- Number of holders
- 145
- Value change
- +$23,930,958
- Number of buys
- 62
- Number of sells
- 56
- Shares outstanding
- 305,667,944
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
145
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
1/15
Latest evidence
30 Sep 2024
13F
13D/G
3/4/5
Lead comparable stake: 4.4%
14 rows are not safely comparable across share classes.
13D/G row: BAILLIE GIFFORD & CO
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 4.4%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Comparable ownership
Top 1
BAILLIE GIFFORD & CO
4.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
13D/G
Company
|
4.4%
Reported 13D/G
· 30 Sep 2024
|
$33,526,228
12,894,703 shares
|
— | 30 Sep 2024 |
| DCVC Bio, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$199,508
73,892 shares
|
— | 18 Jun 2021 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$71,566,664
27,525,640 shares
|
— | 30 Sep 2024 |
| John Hamer |
3/4/5
Director
|
—
denominator unverified
|
$39,783,482
14,734,623 shares
|
— | 31 Aug 2021 |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$27,622,881
10,624,185 shares
|
— | 30 Sep 2024 |
| Prosight Management, LP |
13F
Company
|
—
denominator unverified
|
$23,606,801
9,079,539 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
145
Shares
113,909,183
Rows available
145
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
139
Q4 2024 holders
145
Holder diff
6
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|